KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Interest Expenses (2022 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Interest Expenses for 4 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses changed 0.07% to $3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.8 million through Dec 2025, up 1.71% year-over-year, with the annual reading at $11.8 million for FY2025, 1.71% up from the prior year.
  • Interest Expenses hit $3.0 million in Q4 2025 for Adaptive Biotechnologies, down from $3.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $3.7 million in Q3 2023 to a low of $653000.0 in Q3 2022.
  • Historically, Interest Expenses has averaged $3.0 million across 4 years, with a median of $3.0 million in 2025.
  • Biggest five-year swings in Interest Expenses: soared 459.26% in 2023 and later fell 25.21% in 2024.
  • Year by year, Interest Expenses stood at $3.6 million in 2022, then fell by 15.98% to $3.0 million in 2023, then fell by 1.99% to $3.0 million in 2024, then rose by 0.07% to $3.0 million in 2025.
  • Business Quant data shows Interest Expenses for ADPT at $3.0 million in Q4 2025, $3.0 million in Q3 2025, and $2.9 million in Q2 2025.